Kevin S. Chu

1.3k total citations
15 papers, 977 citations indexed

About

Kevin S. Chu is a scholar working on Biomaterials, Oncology and Biomedical Engineering. According to data from OpenAlex, Kevin S. Chu has authored 15 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomaterials, 6 papers in Oncology and 4 papers in Biomedical Engineering. Recurrent topics in Kevin S. Chu's work include Nanoparticle-Based Drug Delivery (8 papers), Atmospheric chemistry and aerosols (3 papers) and Cancer Treatment and Pharmacology (3 papers). Kevin S. Chu is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Atmospheric chemistry and aerosols (3 papers) and Cancer Treatment and Pharmacology (3 papers). Kevin S. Chu collaborates with scholars based in United States, Germany and South Korea. Kevin S. Chu's co-authors include Joseph M. DeSimone, J. Christopher Luft, Mary E. Napier, William C. Zamboni, Charles J. Bowerman, Ryan Kingsbury, Warefta Hasan, Orlando Coronell, Jason D. Surratt and Avram Gold and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nano Letters.

In The Last Decade

Kevin S. Chu

15 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin S. Chu United States 13 350 333 267 256 182 15 977
Siqin He China 16 153 0.4× 319 1.0× 176 0.7× 79 0.3× 36 0.2× 36 764
Anand Gupta United States 10 253 0.7× 106 0.3× 137 0.5× 149 0.6× 40 0.2× 12 687
Bo Teng China 14 117 0.3× 390 1.2× 284 1.1× 93 0.4× 163 0.9× 26 980
Bryce J. Marquis United States 16 204 0.6× 249 0.7× 208 0.8× 39 0.2× 101 0.6× 23 939
Yajuan Zou Japan 12 138 0.4× 160 0.5× 110 0.4× 26 0.1× 230 1.3× 24 716
Keila Isaac‐Olivé Mexico 17 153 0.4× 187 0.6× 226 0.8× 16 0.1× 63 0.3× 78 882
Yi-Xin Chang China 15 107 0.3× 197 0.6× 235 0.9× 24 0.1× 42 0.2× 39 821
Dominic A. Urban Switzerland 12 413 1.2× 436 1.3× 246 0.9× 12 0.0× 60 0.3× 13 1.2k
Meili Shen China 17 129 0.4× 183 0.5× 357 1.3× 11 0.0× 264 1.5× 51 1.1k

Countries citing papers authored by Kevin S. Chu

Since Specialization
Citations

This map shows the geographic impact of Kevin S. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin S. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin S. Chu more than expected).

Fields of papers citing papers by Kevin S. Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin S. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin S. Chu. The network helps show where Kevin S. Chu may publish in the future.

Co-authorship network of co-authors of Kevin S. Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin S. Chu. A scholar is included among the top collaborators of Kevin S. Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin S. Chu. Kevin S. Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Riedel, Theran P., Ying‐Hsuan Lin, Kevin S. Chu, et al.. (2016). Constraining condensed-phase formation kinetics of secondary organic aerosol components from isoprene epoxydiols. Atmospheric chemistry and physics. 16(3). 1245–1254. 37 indexed citations
2.
Bowerman, Charles J., James D. Byrne, Kevin S. Chu, et al.. (2016). Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer. Nano Letters. 17(1). 242–248. 92 indexed citations
3.
Rattanavaraha, Weruka, Kevin S. Chu, Sri Hapsari Budisulistiorini, et al.. (2016). Assessing the impact of anthropogenic pollution on isoprene-derived secondary organic aerosol formation in PM 2.5 collected from the Birmingham, Alabama, ground site during the 2013 Southern Oxidant and Aerosol Study. Atmospheric chemistry and physics. 16(8). 4897–4914. 96 indexed citations
4.
Sambade, Maria J., Allison M. Deal, Allison N. Schorzman, et al.. (2016). Efficacy and Pharmacokinetics of a Modified acid-labile docetaxel-PRINT ® Nanoparticle Formulation Against non-small-cell Lung Cancer Brain Metastases. Nanomedicine. 11(15). 1947–1955. 25 indexed citations
5.
Kingsbury, Ryan, Kevin S. Chu, & Orlando Coronell. (2015). Energy storage by reversible electrodialysis: The concentration battery. Journal of Membrane Science. 495. 502–516. 74 indexed citations
6.
Gharpure, Kshipra M., Kevin S. Chu, Charles J. Bowerman, et al.. (2014). Metronomic Docetaxel in PRINT Nanoparticles and EZH2 Silencing Have Synergistic Antitumor Effect in Ovarian Cancer. Molecular Cancer Therapeutics. 13(7). 1750–1757. 26 indexed citations
7.
Konno, Sensuke, et al.. (2014). Potent Anticancer Effects of Bioactive Mushroom Extracts (Phellinus linteus) on a Variety of Human Cancer Cells. Journal of Clinical Medicine Research. 7(2). 76–82. 34 indexed citations
8.
Chu, Kevin S., Allison N. Schorzman, J. Christopher Luft, et al.. (2014). Particle Replication in Nonwetting Templates Nanoparticles with Tumor Selective Alkyl Silyl Ether Docetaxel Prodrug Reduces Toxicity. Nano Letters. 14(3). 1472–1476. 37 indexed citations
9.
Chu, Kevin S., et al.. (2014). A versatile acid-labile linker for antibody–drug conjugates. MedChemComm. 5(9). 1355–1358. 10 indexed citations
10.
Lin, Ying‐Hsuan, Sri Hapsari Budisulistiorini, Kevin S. Chu, et al.. (2014). Light-Absorbing Oligomer Formation in Secondary Organic Aerosol from Reactive Uptake of Isoprene Epoxydiols. Environmental Science & Technology. 48(20). 12012–12021. 125 indexed citations
11.
Morton, Stephen W., Kevin P. Herlihy, Kevin E. Shopsowitz, et al.. (2013). Scalable Manufacture of Built‐to‐Order Nanomedicine: Spray‐Assisted Layer‐by‐Layer Functionalization of PRINT Nanoparticles (Adv. Mater. 34/2013). Advanced Materials. 25(34). 4706–4706. 3 indexed citations
12.
Chu, Kevin S., Allison N. Schorzman, Charles J. Bowerman, et al.. (2013). Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy. Biomaterials. 34(33). 8424–8429. 100 indexed citations
13.
Chu, Kevin S., Warefta Hasan, Sumit Rawal, et al.. (2012). Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft. Nanomedicine Nanotechnology Biology and Medicine. 9(5). 686–693. 127 indexed citations
14.
Hasan, Warefta, Kevin S. Chu, Anuradha Gullapalli, et al.. (2011). Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer. Nano Letters. 12(1). 287–292. 143 indexed citations
15.
Doiron, Amber L., et al.. (2008). Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI. Proceedings of the National Academy of Sciences. 105(45). 17232–17237. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026